Johnson Controls (JCI) PT Raised to $170 at UBS

UBS analyst Amit Mehrotra raised the price target on Johnson Controls (NYSE: JCI) to $170.00 (from $160.00) while maintaining a Buy rating.

The analyst commented, "JCI shares underperformed a bit today [Wednesday] on good, but not blockbuster results. In a tape dominated by big beats from data center exposed companies, the more modest beat and raise coupled with high expectations led to a 1% decline in shares. But nothing about our bullish stance has changed. If anything, we’re even more positive on the outlook for earnings revisions. For example, after our post results call back with the company, we believe there’s a strong case for accelerating revenue and earnings growth in fiscal 2027 (ending Sept. 2027), with potential for Commercial HVAC revenue growth to reach mid teens+ at some point next year. If achieved, this could allow for meaningful positive revisions over the medium-term. The bottom line is JCI remains our top pick across our entire coverage universe, and today’s results further support the opportunity we see in shares."

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• BTIG Upgrades Medtronic, Inc. (MDT) to Buy
• SpaceX files for 555.56M share IPO at $135/sh